临床试验市场规模、份额、成长分析，按阶段、按服务类型、按治疗领域、按应用、按地区 - 行业预测，2024-2031 年

2022年全球临床试验市场规模将为482亿美元，预测期内（2024-2031年）复合年增长率为8.7%，从2023年的523.9亿美元增至2031年的1021亿美元。美国2000万美元。

由于医疗保健的进步、对新型疗法的需求不断增加以及监管机构的支持，全球临床试验市场正在经历强劲增长。市场涵盖临床前、I期、II期、III期、IV期等临床试验各阶段，涵盖肿瘤学、心臟科、神经科等多个治疗领域。包括人工智慧和资料分析整合在内的技术创新正在增强试验设计、患者招募和资料管理。此外，慢性病盛行率的上升和个人化医疗的推动进一步加速了市场扩张。市场也见证了向分散式临床试验的转变，这提供了更大的灵活性和效率。然而，该市场面临高成本、监管要求复杂、吸引患者困难等挑战。儘管存在这些挑战，但由于持续的技术创新和对改善患者治疗效果日益浓厚的兴趣，市场有望实现显着增长。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 市场生态系统
• 重点投资分析
• 关键成功因素
• 竞争程度
• 价值链分析
• 价格分析
• 技术分析
• 监管分析

临床试验市场：按阶段

• 市场概况
• III期临床试验
• II期临床试验
• IV期临床试验
• I期临床试验

临床试验市场：按服务类型

• 市场概况
• 化验服务
• 生物分析测试服务
  • 基于细胞的检测
  • 病毒测试
  • 血清学、免疫抗原性、中和抗体
  • PK/PD测试
  • 方法开发、最佳化和检验
  • 生物标记测试
  • 其他生物分析测试服务
• 去中心化临床试验服务
• 病患招募服务
• 场地识别服务
• 分析测试服务
• 供应及物流服务
• 通讯协定设计服务
• 资料管理服务
• 医疗设备检测服务
• 其他服务

临床试验市场：按治疗领域

• 市场概况
• 肿瘤学
• 感染疾病
• 神经病学
• 代谢紊乱
• 免疫学
• 心臟病学
• 遗传疾病
• 妇女健康
• 其他治疗领域

临床试验市场：依应用分类

• 市场概况
• 小分子
• 单株抗体
• 疫苗
• 细胞/基因治疗
• 其他用途

临床试验市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Thermo Fisher Scientific, Inc.（US）
• IQVIA, Inc.（US）
• ICON plc（Ireland）
• Laboratory Corporation of America Holdings（US）
• Syneos Health（US）
• WuXi AppTec（China）
• Charles River Laboratories（US）
• Parexel International Corporation（US）
• Fortrea, Inc.（US）
• Medpace（US）
• SGS（Switzerland）
• Frontage Labs（US）
• ACM Global Laboratories（US）
• Advanced Clinical（US）
• PSI（Switzerland）
• BioAgile（India）
• Clinical Trial Service（Unknown）
• Worldwide Clinical Trials（US）
• Pepgra（India）
• CTI Clinical Trial and Consulting Services（US）

Global Clinical Trials Market size was valued at USD 48.20 billion in 2022 and is poised to grow from USD 52.39 billion in 2023 to USD 102.12 billion by 2031, growing at a CAGR of 8.7% in the forecast period (2024-2031).

Global clinical trials market is experiencing robust growth, driven by advancements in healthcare, increasing demand for novel therapeutics, and regulatory support. The market encompasses various phases of clinical trials, including preclinical, phase I, II, III, and IV, catering to diverse therapeutic areas such as oncology, cardiology, and neurology. Technological innovations, including the integration of artificial intelligence and data analytics, are enhancing trial design, patient recruitment, and data management. Additionally, the rising prevalence of chronic diseases and the push for personalized medicine are further accelerating market expansion. The market is also witnessing a shift towards decentralized clinical trials, which offer greater flexibility and efficiency. However, the market is challenged by high costs, complex regulatory requirements, and patient recruitment difficulties. Despite these challenges, the market is poised for significant growth, driven by continued innovation and the increasing focus on improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Market Segmental Analysis

Global Clinical Trials Market is segmented on the basis of phase, service type, therapeutic area, application, and region. By phase, market is segmented into Phase III Clinical Trials, Phase II Clinical Trials, Phase IV Clinical Trials, and Phase I Clinical Trials. By service type, market is segmented into Laboratory Services, Bioanalytical Testing Services, Decentralized Clinical Trial Services, Patient Recruitment Services, Site Identification Services, Analytical Testing Services, Supply & Logistics Services, Protocol Designing Services, Data Management Services, Medical Device Testing Services, and Other Services. By therapeutic area, market is segmented into Oncology, Infectious Diseases, Neurology, Metabolic Disorders, Immunology, Cardiology, Genetic Diseases, Women's Health, and Other Therapeutic Areas. By application, market is segmented into Small Molecules, Monoclonal Antibodies, Vaccines, Cell & Gene Therapy, and Other Applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Clinical Trials Market

Technological advancements are a major driver of the clinical trials market. Innovations such as electronic data capture (EDC) systems, wearable devices, and mobile health applications are transforming how clinical trials are conducted. These technologies enhance data accuracy, streamline patient monitoring, and improve the efficiency of trial operations. For instance, EDC systems facilitate real-time data collection and analysis, reducing the risk of errors and expediting regulatory submissions. Wearable devices enable continuous health monitoring, providing valuable insights into patient responses and treatment efficacy. Mobile health applications improve patient engagement and adherence, allowing for remote participation and data collection. As technology continues to evolve, it is expected to drive further growth in the clinical trials market by making trials more efficient, cost-effective, and patient-centric.

Restraints in the Clinical Trials Market

High costs represent a significant restraint in the clinical trials market. Conducting clinical trials involves substantial expenses, including those related to trial design, site management, patient recruitment, and regulatory compliance. The costs associated with hiring specialized staff, purchasing equipment, and managing data are substantial, often reaching millions of dollars for a single trial. Additionally, the lengthy and complex process of obtaining regulatory approvals and ensuring compliance with international standards further inflates costs. These financial burdens can be particularly challenging for smaller organizations and biotech firms with limited resources. As a result, the high cost of clinical trials can slow down the development of new therapies and limit the participation of smaller players in the market.

Market Trends of the Clinical Trials Market

Decentralized clinical trials (DCTs) are emerging as a significant trend in the clinical trials market. This approach leverages technology to conduct trials remotely, reducing the need for traditional site-based visits. DCTs utilize digital tools such as mobile apps, wearable devices, and telemedicine to facilitate patient participation and data collection from home or local healthcare providers. This model offers several advantages, including increased patient accessibility, improved retention rates, and reduced operational costs. By minimizing the logistical challenges associated with traditional trials, DCTs enable faster recruitment and more diverse patient populations. The trend towards decentralized trials is expected to continue growing as stakeholders seek more flexible, patient-centric, and efficient methods for conducting clinical research, ultimately enhancing trial outcomes and accelerating the development of new treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Ecosystem of the Market
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis

Clinical Trials Market by Phase

• Market Overview
• Phase III Clinical Trials
• Phase II Clinical Trials
• Phase IV Clinical Trials
• Phase I Clinical Trials

Clinical Trials Market by Service Type

• Market Overview
• Laboratory Services
• Bioanalytical Testing Services
  • Cell-Based Assays
  • Virology Testing
  • Serology, Immunogenicity, And Neutralizing Antibodies
  • PK/PD Testing
  • Method Development, Optimization, And Validation
  • Biomarker Testing
  • Other Bioanalytical Testing Services
• Decentralized Clinical Trial Services
• Patient Recruitment Services
• Site Identification Services
• Analytical Testing Services
• Supply & Logistics Services
• Protocol Designing Services
• Data Management Services
• Medical Device Testing Services
• Other Services

Clinical Trials Market by Therapeutic Area

• Market Overview
• Oncology
• Infectious Diseases
• Neurology
• Metabolic Disorders
• Immunology
• Cardiology
• Genetic Diseases
• Women's Health
• Other Therapeutic Areas

Clinical Trials Market by Application

• Market Overview
• Small Molecules
• Monoclonal Antibodies
• Vaccines
• Cell & Gene Therapy
• Other Applications

Clinical Trials Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Labs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Clinical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgile (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Trial Service (Unknown)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pepgra (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CTI Clinical Trial and Consulting Services (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments